Secondary bile acids: An underrecognized cause of colon cancer

World Journal of Surgical Oncology

Volumn 12, Issue 1, 2014, Pages

  Ajouz, Hana ^a   Mukherji, Deborah ^a   Shamseddine, Ali ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; DEOXYCHOLIC ACID; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; K RAS PROTEIN; LITHOCHOLIC ACID; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PREGNANE X RECEPTOR; PROTEIN BCL XL; PROTEIN KINASE C; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SATURATED FATTY ACID; SECONDARY BILE ACID; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ANEUPLOIDY; APOPTOSIS; BEEF; BILE SECRETION; CANCER RISK; CATABOLISM; CELL MEMBRANE; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; COLON CARCINOMA; COLON MUCOSA; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; DISEASE ASSOCIATION; DNA DAMAGE; GENE MUTATION; GENOMIC INSTABILITY; GENOTOXICITY; HUMAN; INTESTINE EPITHELIUM; LIPID DIET; MICRONUCLEUS; MITOCHONDRIAL MEMBRANE; OXIDATIVE STRESS; POSITIVE FEEDBACK; RED MEAT; REVIEW; SIGNAL TRANSDUCTION; VITAMIN D DEFICIENCY; COLON TUMOR; COMPLICATION; GASTROINTESTINAL NEOPLASMS; METABOLISM; PATHOPHYSIOLOGY; PROGNOSIS;

BILE ACIDS AND SALTS; COLONIC NEOPLASMS; GASTROINTESTINAL NEOPLASMS; HUMANS; PROGNOSIS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 84901846653     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-12-164     Document Type: Review

References (57)

1. Fiorucci S, Cipriani S, Mencarelli A, Renga B, Distrutti E, Baldelli F. Counter-regulatory role of bile acid activated receptors in immunity and inflammation. Curr Mol Med 2010, 10:579-595.
2. Hofmann AF. Detoxification of lithocholic acid, a toxic bile acid: relevance to drug hepatotoxicity. Drug Metab Rev 2004, 36:703-722. 10.1081/DMR-200033475, 15554243.
3. Cook JW, Kennaway EL, Kennaway NM. Production of tumors in mice by deoxycholic acid. Nature 1940, 145:627.
4. Payne CM, Bernstein C, Dvorak K, Bernstein H. Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis. Clin Exp Gastroenterol 2008, 1:19-47. 3108627, 21677822.
5. Dvorak K, Payne CM, Chavarria M, Ramsey L, Dvorakova B, Bernstein H, Holubec H, Sampliner RE, Guy N, Condon A, Bernstein C, Green SB, Prasad A, Garewal HS. Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus. Gut 2007, 56:763-771. 10.1136/gut.2006.103697, 1954874, 17145738.
6. Dixon MFMN, Neville PM, Moayyedi P, Axon AT. Bile reflux gastritis and intestinal metaplasia at the cardia. Gut 2002, 51:351-355. 10.1136/gut.51.3.351, 1773352, 12171955.
7. Ross RK, Hartnett NM, Bernstein L, Henderson BE. Epidemiology of adenocarcinomas of the small intestine: is bile a small bowel carcinogen?. Br J Cancer 1991, 63:143-145. 10.1038/bjc.1991.29, 1971637, 1989654.
8. Ohtaki YHT, Hiramatsu K, Kanitani M, Ohshima T, Nomura M, Wakita H, Aburada M, Miyamoto KI. Deoxycholic acid as an endogenous risk factor for hepatocarcinogenesis and effects of gomisin A, a lignan component of Schizandra fruits. Anticancer Res 1996, 16:751-755.
9. Adachi TTY, Kuroki T, Mishima T, Kitasato A, Fukuda K, Tsutsumi R, Kanematsu T. Bile-reflux into the pancreatic ducts is associated with the development of intraductal papillary carcinoma in hamsters. J Surg Res 2006, 136:106-111. 10.1016/j.jss.2006.04.025, 16863651.
10. Komichi D, Tazuma S, Nishioka T, Hyogo H, Chayama K. Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholangiocytes via oxidative DNA damage. Free Radic Biol Med 2005, 39:1418-1427. 10.1016/j.freeradbiomed.2005.07.005, 16274877.
11. Björkhem I, Eggertsen G. Genes involved in initial steps of bile acid synthesis. Curr Opin Lipidol 2001, 12:97-103. 10.1097/00041433-200104000-00002, 11264980.
12. Nagengast FM, Grubben MJ, van Munster IP. Role of bile acids in colorectal carcinogenesis. Eur J Cancer 1995, 31A:1067-1070.
13. Hofmann AF, Cravetto C, Molino G, Belforte G, Bona B. Simulation of the metabolism and enterohepatic circulation of endogenous deoxycholic acid in humans using a physiologic pharmacokinetic model for bile acid metabolism. Gastroenterology 1987, 93:693-709.
14. Hofmann AF. The Continuing Importance of Bile Acids in Liver and Intestinal Disease. Arch Intern Med 1999, 159:2647-2658. 10.1001/archinte.159.22.2647, 10597755.
15. Hofmann AF, Rods AA. Physicochemical properties of bile acids and their relationship to biological properties: an overview of the problem. J Lipid Res 1984, 25:1477-1489.
16. Berg A. Nutrition, development, and population growth. Popul Bull 1973, 29:3-37.
17. Kirkegaard H, Johnsen NF, Christensen J. Association of adherence to lifestyle recommendations and risk of colorectal cancer: a prospective Danish cohort study. BMJ 2010, 341:c5504. 10.1136/bmj.c5504, 2965150, 20978063.
18. Bayerdörffer E, Mannes GA, Richter WO, Ochsenkühn T, Wiebecke B, Köpcke W, Paumgartner G. Increased serum deoxycholic acid levels in men with colorectal adenomas. Gastroenterology 1993, 104:145-151.
19. Bayerdörffer E, Mannes GA, Ochsenkühn T, Dirschedl P, Wiebecke B, Paumgartner G. Unconjugated secondary bile acids in the serum of patients with colorectal adenomas. Gut 1995, 36:268-273. 10.1136/gut.36.2.268, 1382415, 7883228.
20. Behar J. Physiology and Pathophysiology of the Biliary Tract: The Gallbladder and Sphincter of Oddi. Rev ISRN Physiol 2013, 2013:Article ID 837630.
21. Pai R, Tarnawski AS, Tran T. Deoxycholic Acid Activates -Catenin Signaling Pathway and Increases Colon Cell Cancer Growth and Invasiveness. Mol Biol Cell 2004, 15:2156-2163. 10.1091/mbc.E03-12-0894, 404012, 15004225.
22. Crowley-Weber CL, Dvorakova K, Crowley C, Bernstein H, Bernstein C, Garewal H, Payne CM. Nicotine increases oxidative stress, activates NF-kappaB and GRP78, induces apoptosis and sensitizes cells to genotoxic/xenobiotic stresses by a multiple stress inducer, deoxycholate: relevance to colon carcinogenesis. Chem Biol Interact 2003, 145:53-66. 10.1016/S0009-2797(02)00162-X, 12606154.
23. Jenkins D, Wolever TM, Rao AV, Hegele RA, Mitchell SJ, Ransom TP, Boctor DL, Spadafora PJ, Jenkins AL, Mehling C, Relle LK, Connelly PW, Story JA, Furumoto EJ, Corey P, Wursch P. Effect on blood lipids of very high intakes of fiber in diets low in saturated fat and cholesterol. N Engl J Med 1993, 329:21-26. 10.1056/NEJM199307013290104, 8389421.
24. Newmark HL, Yang K, Kurihara N, Fan K, Augenlicht LH, Lipkin M. Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer. Carcinogenesis 2009, 30:88-92. 2722141, 19017685.
25. Lorenzen JK, Nielsen S, Holst JJ, Tetens I, Rehfeld JF, Astrup A. Effect of dairy calcium or supplementary calcium intake on postprandial fat metabolism, appetite, and subsequent energy intake. Am J Clin Nutr 2007, 85:678-687.
26. Jean-Louis S, Akare S, Ali MA, Mash EA, Meuillet E, Martinez JD. Deoxycholic Acid Induces Intracellular Signaling through Membrane Perturbations. J Biol Chem 2006, 281:14948-14960. 10.1074/jbc.M506710200, 16547009.
27. Chen X, Resh MD. Cholesterol Depletion from the Plasma Membrane Triggers Ligand-independent Activation of the Epidermal Growth Factor Receptor. J Biol Chem 2002, 227:49631-49637.
28. Sagawa H, Tazuma S, Kajiyama G. Protection against hydrophobic bile salt-induced cell membrane damage by liposomes and hydrophilic bile salts. Am J Physiology 1993, 264:G835-G839.
29. Stenman LK, Holma R, Korpela R. High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids. World J Gastroenterol 2012, 18:923-929. 10.3748/wjg.v18.i9.923, 3297051, 22408351.
30. Ochsenkühn T, Bayerdörffer E, Meining A, Schinkel M, Thiede C, Nüssler V, Sackmann M, Hatz R, Neubauer A, Paumgartner G. Colonic mucosal proliferation is related to serum deoxycholic acid levels. Cancer 2000, 85:1664-1669.
31. Hylemon PB, Zhou H, Dent P. Bile acids as regulatory molecules. J Lipid Res 2009, 50:1509-1520. 10.1194/jlr.R900007-JLR200, 2724047, 19346331.
32. Rao YP, Stravitz RT, Vlahcevic ZR, Gurley EC, Sando JJ, Hylemon PB. Activation of protein kinase C alpha and delta by bile acids: correlation with bile acid structure and diacylglycerol formation. J Lipid Res 1997, 38:2446-2454.
33. D'Errico I, Moschetta A. Nuclear receptors, intestinal architecture and colon cancer: an intriguing link. Cell Mol Life Sci 2008, 65:1523-1543. 10.1007/s00018-008-7552-1, 18278436.
34. Bernstein H, Bernstein C, Payne CM, Dvorak K. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol 2009, 15:3329-3340. 10.3748/wjg.15.3329, 2712893, 19610133.
35. Chen WD, Wang YD, Meng Z, Zhang L, Huang W. Nuclear bile acid receptor FXR in the hepatic regeneration. Biochim Biophys Acta 2011, 1812:888-892. 10.1016/j.bbadis.2010.12.006, 21167938.
36. Maran RR, Thomas A, Roth M, Sheng Z, Esterly N, Pinson D, Gao X, Zhang Y, Ganapathy V, Gonzalez FJ, Guo GL. Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development. J Pharmacol Exp The 2009, 328:469-477.
37. Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, Haussler MR, Mangelsdorf DJ. Vitamin D receptor as an intestinal bile acid sensor. Science 2002, 296:1313-1316. 10.1126/science.1070477, 12016314.
38. Zhang B, Xie W, Krasowski MD. PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics. Pharmacogenomics 2008, 9:1695-1709. 10.2217/14622416.9.11.1695, 2593625, 19018724.
39. Staudinger JL, Goodwin B, Jones SA, Hawkins-Brown D, MacKenzie KI, LaTour A, Liu Y, Klaassen CD, Brown KK, Reinhard J, Willson TM, Koller BH, Kliewer SA. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci U S A 2001, 98:3369-3374. 10.1073/pnas.051551698, 30660, 11248085.
40. Modica S, Murzilli S, Salvatore L, Schmidt DR, Moschetta A. Nuclear bile acid receptor FXR protects against intestinal tumorigenesis. Res Cancer 2008, 68:9589-9594.
41. Tsioulias G, Godwin TA, Goldstein MF, McDougall CJ, Ngoi SS, DeCosse JJ, Rigas B. Loss of colonic HLA antigens in familial adenomatous polyposis. Cancer Res 1992, 52:3449-3452.
42. Arvind P, Papavassiliou ED, Tsioulias GJ, Duceman BW, Lovelace CI, Geng W, Staiano-Coico L, Rigas B. Lithocholic acid inhibits the expression of HLA class I genes in colon adenocarcinoma cells. Differential effect on HLA-A, -B and -C loci. Mol Immunol 1994, 31:607-614. 10.1016/0161-5890(94)90168-6, 8196671.
43. Bernstein H, Bernstein C, Payne CM, Dvorakova K, Garewal H. Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res 2005, 589:47-65. 10.1016/j.mrrev.2004.08.001, 15652226.
44. Reinehr R, Becker S, Eberle A, Grether-Beck S, Haussinger D. Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J Biol Chem 2005, 280:27179-27194. 10.1074/jbc.M414361200, 15917250.
45. Strauch ED, Bass BL, Rao JN, Vann JA, Wang JY. NF-kappaB regulates intestinal epithelial cell and bile salt-induced migration after injury. Ann Surg 2003, 237:494-501. 1514469, 12677145.
46. Karin M. NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol 2009, 1:a000141. 2773649, 20066113.
47. Glinghammar B, Inoue H, Rafter JJ. Deoxycholic acid causes DNA damage in colonic cells with subsequent induction of caspases, COX-2 promoter activity and the transcription factors NF-kB and AP-1. Oxford J 2002, 23:839-845.
48. Powolny A, Xu J, Loo G. Deoxycholate induces DNA damage and apoptosis in human colon epithelial cells expressing either mutant or wild-type p53. Int J Biochem Cell Biol 2001, 33:193-203. 10.1016/S1357-2725(00)00080-7, 11240376.
49. Armaghany T, Wilson JD, Chu Q, Mills G. Genetic Alterations in Colorectal Cancer. Gastrointest Cancer Res 2012, 5:19-27. 3348713, 22574233.
50. Degirolamo C, Modica S. Palasciano G Bile acids and colon cancer: Solving the puzzle with nuclear receptors. Trends Mol Med 2011, 17:564-572. 10.1016/j.molmed.2011.05.010, 21724466.
51. Narahara H, Tatsuta M, Iishi H, Baba M, Uedo N, Sakai N, Yano H, Ishiguro S. K-ras point mutation is associated with enhancement by deoxycholic acid of colon carcinogenesis induced by azoxymethane, but not with its attenuation by all-trans-retinoic acid. Int J Cancer 2000, 88:157-161. 10.1002/1097-0215(20001015)88:2<157::AID-IJC2>3.0.CO;2-B, 11004662.
52. Bernstein H, Holubec H, Warneke JA, Garewal H, Earnest DL, Payne CM, Roe DJ, Cui H, Jacobson EL, Bernstein C. Patchy field defects of apoptosis resistance and dedifferentiation in flat mucosa of colon resections from colon cancer patients. Ann Surg Oncol 2002, 9:505-517. 10.1007/BF02557276, 12052764.
53. Perez MJ, Briz O. Bile-acid-induced cell injury and protection. World J Gastroenterol 2009, 15:1677-1689. 10.3748/wjg.15.1677, 2668773, 19360911.
54. Yui S, Kanamoto R, Saeki T. Biphasic regulation of cell death and survival by hydrophobic bile acids in HCT116 cells. Nutr Cancer 2009, 61:374-380. 10.1080/01635580802582744, 19373611.
55. Lowe SW, Lin AW. Apoptosis in cancer. Oxford J 1999, 21:485-495.
56. Yui S, Kanamoto R, Saeki T. Deoxycholic acid can induce apoptosis in the human colon cancer cell line HCT116 in the absence of Bax. Nutr Cancer 2007, 60:91-96.
57. Krajewska M, Moss SF, Krajewski S, Song K, Holt PR, Reed JC. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res 1996, 56:2422-2427.